13.06.2007 11:00:00
|
Arrowhead Scheduled to Be Listed on Russell 3000 Index
Arrowhead Research Corporation (NASDAQ:ARWR) announced today that it is
scheduled to join the Russell 3000TM Index when
the Russell Investment Group reconstitutes its family of U.S. indexes on
June 22, 2007, according to a preliminary membership list posted on
Monday, June 11, 2007, on www.russell.com.
Arrowhead is already a member of the Russell Microcap Index.
"Arrowhead joined the Russell Microcap Index
just one year ago. We are pleased to have achieved inclusion in the more
exclusive Russell 3000 Index as well,” said R.
Bruce Stewart, Chairman and CEO of Arrowhead. "The
growth that qualified Arrowhead for Russell 3000 was made possible by
the vision and hard work of the talented people at Arrowhead and our
majority-owned subsidiaries.”
Russell, a global leader in multi-manager investment services, provides
investment products and services in 44 countries. Russell manages more
than $167 billion in assets and advises clients worldwide representing
$2.4 trillion. Russell indexes are widely used by investment managers
and institutional investors for index funds and as benchmarks for both
passive and active investment strategies. An industry-leading $4
trillion in assets currently are evaluated and benchmarked against these
Russell indexes.
About Arrowhead Research Corporation
Arrowhead Research Corporation (www.arrowheadresearch.com)
(NASDAQ:ARWR) is
a leading nanotechnology company commercializing new technologies in the
areas of life sciences, electronics, and energy. Arrowhead is building
value for shareholders through the progress of majority-owned
subsidiaries founded on nanotechnologies originally developed at
universities. The company works closely with universities to source
early stage deals and to generate rights to intellectual property
covering promising new nanotechnologies. Currently, Arrowhead has four
subsidiaries commercializing nanotech products and applications,
including anti-cancer drugs, RNAi therapeutics, carbon-based
electronics, and compound semiconductor materials.
Safe Harbor Statement under the Private Securities Litigation Reform
Act of 1995: This news release contains forward-looking statements within the
meaning of the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995. These statements are based upon our
current expectations and speak only as of the date hereof. Our actual
results may differ materially and adversely from those expressed in any
forward-looking statements as a result of various factors and
uncertainties, including the future success of our scientific studies,
our ability to successfully develop products, rapid technological change
in our markets, changes in demand for our future products, legislative,
regulatory and competitive developments and general economic conditions.
Our latest Annual Report on Form 10-K, recent and forthcoming Quarterly
Reports on Form 10-Q, recent Current Reports on Form 8-K, our
Registration Statements on Form S-3, and other SEC filings discuss some
of the important risk factors that may affect our business, results of
operations and financial condition. We undertake no obligation to revise
or update publicly any forward-looking statements for any reason.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Arrowhead Research Corp.mehr Nachrichten
Keine Nachrichten verfügbar. |